The expression of intergenic LINC00472 correlates with BC progression and patient survival; particularly, its over-expression was found to be associated with low tumor grade, early-stage disease, estrogen or progesterone receptor positivity, and less cancer aggressiveness [110], while lower expression was associated with aggressive tumor features and unfavorable disease outcomes [110,111]. The gene discussed is PGR; the disease is neoplasm.